| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332121A1 Methods for inhibiting tef-3 activity |
| 01/06/2000 | CA2330565A1 Growth factor modulators |
| 01/05/2000 | EP0968700A1 Material intended to remineralise organomineral tissues |
| 01/05/2000 | EP0968432A1 Growth factor-dependent diseases |
| 01/05/2000 | EP0968304A1 Identification of inhibitors of protein tyrosine kinase 2 |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968228A1 Calcium phosphopeptide complexes |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968200A1 Calcitonin mimetics |
| 01/05/2000 | EP0967989A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 01/05/2000 | EP0967973A2 Mediation of cytokines by melanin |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240144A External use tradtional Chinese Medicine for treating hyperosteogeny, prolapse of lumbar intervertebral disc and various soft tissue injuries |
| 01/04/2000 | US6011159 Processes and intermediates for preparing substituted indazole derivatives |
| 01/04/2000 | US6011068 Carbocyclic-alkyl secondary amines |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011026 P-(aminoalkoxyphenyl)-steroid derivative |
| 12/29/1999 | WO1999067809A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999066945A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | WO1999066925A1 Protease inhibitors |
| 12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | WO1999066913A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 12/29/1999 | WO1999047156A3 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 12/29/1999 | EP0966968A1 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 12/29/1999 | EP0966439A1 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966424A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 12/29/1999 | EP0966299A2 Novel pharmaceutical compositions |
| 12/29/1999 | EP0966295A1 Calcareous material |
| 12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CN1239892A Use of equilenin as antioxidant |
| 12/29/1999 | CN1239891A Use of 17 '-dihydroequilenin as an antioxidant |
| 12/29/1999 | CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant |
| 12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
| 12/29/1999 | CA2336201A1 Compositions and methods for inhibiting bone resorption |
| 12/29/1999 | CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | CA2335876A1 Protease inhibitors |
| 12/29/1999 | CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | CA2335471A1 Compositions and methods for inhibiting bone resorption |
| 12/28/1999 | US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues |
| 12/28/1999 | US6008230 Treating bone diseases caused by abnormal bone metabolism in human being or animals as the inhibitors of bone resorption or the inhibitors of bone metastasis |
| 12/28/1999 | US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer |
| 12/28/1999 | US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis |
| 12/28/1999 | US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 12/28/1999 | US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease |
| 12/28/1999 | US6007804 Administering dosage of interleukin-6 (il-6) to prevent gout; side effect reduction |
| 12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999065942A1 Cyclic somatostatin analogs |
| 12/23/1999 | WO1999065940A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/23/1999 | WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/23/1999 | WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 12/23/1999 | WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 12/23/1999 | WO1999065880A1 Aryl alkanoylpyridazines |
| 12/23/1999 | WO1999065877A1 Therapeutic biaryl derivatives |
| 12/23/1999 | WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 12/23/1999 | WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/23/1999 | WO1999065519A1 Matrix metalloproteinase proenzyme activator |
| 12/23/1999 | WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 12/23/1999 | WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 12/23/1999 | WO1999065486A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 12/23/1999 | WO1999065482A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 12/23/1999 | WO1999065478A1 Therapeutic compositions and methods of use |
| 12/23/1999 | WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 12/23/1999 | WO1999065310A1 Il-8 receptor antagonists |
| 12/23/1999 | WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 12/23/1999 | DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine |
| 12/23/1999 | CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | CA2335294A1 Inhibitors of transcription factor nf-.kappa.b |
| 12/23/1999 | CA2335293A1 Inhibitors of transcription factor nf-.kappa.b |
| 12/23/1999 | CA2335292A1 Il-8 receptor antagonists |
| 12/23/1999 | CA2335184A1 Cyclic somatostatin analogs |
| 12/23/1999 | CA2335134A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 12/23/1999 | CA2335112A1 Therapeutic combinations for musculoskeletal frailty |
| 12/23/1999 | CA2335078A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 12/23/1999 | CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 12/23/1999 | CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/23/1999 | CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | CA2331332A1 Anti-angiogenic proteins and methods of use thereof |
| 12/22/1999 | EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 12/22/1999 | EP0964856A1 Bicyclic amino acids |
| 12/22/1999 | EP0964851A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 12/22/1999 | EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 12/22/1999 | EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| 12/22/1999 | EP0726954B1 Cytokine antagonists |
| 12/22/1999 | CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4) |
| 12/22/1999 | CN1238951A Nafiverine injection |
| 12/21/1999 | US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists |